Back
Vericel 10K Form
Buy
57
VCEL
Vericel
Last Price:
59.10
Seasonality Move:
43.88%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-08 | 10Q | VCEL/Vericel Quarterly |
| 2023-08-02 | 10Q | VCEL/Vericel Quarterly |
| 2023-05-10 | 10Q | VCEL/Vericel Quarterly |
| 2022-11-09 | 10Q | VCEL/Vericel Quarterly |
| 2022-08-03 | 10Q | VCEL/Vericel Quarterly |
| 2022-05-04 | 10Q | VCEL/Vericel Quarterly |
Receive VCEL News And Ratings
See the #1 stock for the next 7 days that we like better than VCEL
VCEL Financial Statistics
Sales & Book Value
| Annual Sales: | $197.52M |
|---|---|
| Cash Flow: | $-9.23M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $5.23 |
| Price / Book: | 11.33 |
Profitability
| EPS (TTM): | 0.07000 |
|---|---|
| Net Income (TTM): | $3.55M |
| Gross Margin: | $135.58M |
| Return on Equity: | 1.52% |
| Return on Assets: | 0.99% |
Vericel Earnings Forecast
Key Vericel Financial Ratios
- The Gross Profit Margin over the past 28 years for VCEL is 68.64%.
- The Selling, General & Administrative Expenses for VCEL have been equal to 61.26% of Gross Profit Margin.
- The Research & Development expenses have been 10.65% of Revenue.
- The Interest Expense is -18.86% of Operating Income.
- The Net Earning history of VCEL is -1.61% of Total Revenues.
- Per Share Earnings over the last 28 years have been positive in 15 years.
Vericel Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | VCEL |
| CUSIP: | 92346J |
| Website: | vcel.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 4.61 |
| Quick Ratio: | 3.63 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 111.53 |